1. Home
  2. AMWL vs TNYA Comparison

AMWL vs TNYA Comparison

Compare AMWL & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Well Corporation

AMWL

American Well Corporation

HOLD

Current Price

$13.52

Market Cap

179.6M

Sector

Technology

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.68

Market Cap

153.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMWL
TNYA
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
179.6M
153.2M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
AMWL
TNYA
Price
$13.52
$0.68
Analyst Decision
Hold
Strong Buy
Analyst Count
6
3
Target Price
$7.40
$5.33
AVG Volume (30 Days)
86.3K
1.7M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
57.06
54.96
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.71
$0.53
52 Week High
$14.19
$2.35

Technical Indicators

Market Signals
Indicator
AMWL
TNYA
Relative Strength Index (RSI) 59.32 46.25
Support Level $4.71 $0.65
Resistance Level $13.92 $0.81
Average True Range (ATR) 0.74 0.03
MACD 0.05 0.00
Stochastic Oscillator 78.71 50.64

Price Performance

Historical Comparison
AMWL
TNYA

About AMWL American Well Corporation

American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: